Analysis of the mitochondrial proteome would provide valuable insight into the function of this important organelle, which plays key roles in energy metabolism, apoptosis, free radical production, thermogenesis, and calcium signaling. It could also increase our understanding about the mechanisms that promote mitochondrial disease. To identify proteins that are antigenically dominant in human liver mitochondria, we generated >240 hybridoma cell lines from native mitochondrial proteins after cell fusion, screening, and cloning. Antibodies that recognized mitochondrial proteins were identified by screening human liver cDNA expression libraries. In this study, we identified 6 major antigens that were recognized by at least 2 different monoclonal antibodies (mAbs). The proteins that were antigenically dominant were: acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase), aldehyde dehydrogenase 1 family member A1, carbamoyl phosphate synthetase 1, dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex), enoyl coenzyme A hydratase 1, and hydroxysteroid (11-beta) dehydrogenase 1. We also determined the subcellular localizations of these enzymes within the mitochondria using immunohistocytochemistry. We believe that these well-characterized antibodies will provide a valuable resource for the Human Liver Proteome Project (HLPP), and will make studies aimed at investigating liver mitochondrial function far easier to perform in future. Our results provide strong evidence that, (i) depletion of dominant proteins from liver mitochondrial samples is possible and, (ii) the approaches adopted in this study can be used to explore or validate protein-protein interactions in this important organelle. 
The mitochondrion is a highly specialized subcellular organelle. Mitochondria play many crucial and diverse roles that affect normal cellular processes as well as disease pathology. Mitochondria not only supply ATP to the cell, but also play roles in redox cell signaling [1-3], apoptotic cell signaling [4] , and cellular homeostasis. Mitochondrial dysfunction is known to contribute to several human diseases, such as diabetes, cancer, neurodegeneration, and cardiovascular pathology [5] [6] [7] [8] [9] [10] [11] [12] . Specifically, the accumulated damage caused by reactive oxygen and nitrogen species, together with binding of environmental toxins are known to contribute to the development of the more prevalent neu-SPECIAL TOPIC rodegenerative disorders. These include Parkinson's, Alzheimer's, and Huntington's diseases, amyotrophic lateral sclerosis, Down's syndrome, and schizophrenia, as well as the aging process itself [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Mitochondria can also be adversely affected by cancer treatment and some chemicals have been shown to induce mitochondrial-mediated apoptosis in human cancer cells [26] . Because proteins execute mitochondrial function, researchers have traditionally paid more attention to changes in mitochondrial protein structure and function than studying mitochondrial DNA mutation in disease pathology. The identification and analysis of the mitochondrial proteome should, therefore, provide better understanding of the numerous functions of this important organelle and elucidate the mechanisms underlying mitochondrion-related diseases. Monoclonal antibodies (mAbs), with their inherently high specificities and sensitivities, are powerful tools in biological research. Antibody-based technologies (including antibody microarrays) make it possible to detect and quantitate protein expression levels in mitochondria. Furthermore, isolation of mitochondrial oxidative complexes can now be achieved using mitochondrial protein-specific antibodies [27] . To keep pace with the capabilities of the new proteomics technologies will require access to a large number of well characterized antibodies.
In earlier studies, the proteins that induce T-cell responses resulting in antibody generation were classified as antigenically dominant proteins. Identification and characterization of immunodominant proteins or immunodominant epitopes in protein mixtures is one of the most important issues in vaccine design and monoclonal antibody generation. It has been demonstrated that immunodominance, involving a B lymphocyte response, is usually limited to a small proportion of the potential determinants of a protein antigen [27] . Several aspects that appear to be involved in immunodominance have been investigated, such as processing of the antigen, peptide competition for class II presentation, and T-cell recognition of immunodominant epitopes, for example [28, 29] .
In this paper we generated a hybridoma bank by immunizing mice with isolated mitochondria, and fractionated mitochondrial protein mixtures which contained numerous proteins. In an earlier paper, we described the approaches taken to identify mAb specificity, using mass spectrometry and cDNA expression library screening [30] . Using these approaches, in this study, we identified 19 target proteins that were recognized by 244 hybridoma supernatants. Among these target proteins, six proteins were recognized by two or more hybridomas. We defined these six proteins as antigenically dominant proteins, because of their strong ability to induce antibody responses in immunized mice. These results enabled us to test the mAbs for their ability to deplete the recognized protein from liver tissue lysates. The results of these studies will guide future research aimed at generating monoclonal antibodies against the less immunodominant proteins within liver tissue.
Materials and methods

Chemicals and liver tissue samples
Unless otherwise indicated, all biochemicals were purchased from Sigma (St. Louis, MO, USA) or Bio-Rad (Hercules, CA, USA). ing BCA-reagent (Pierce, Chicago, IL, USA) against a standard curve constructed using BSA. For animal immunization and mAb characterization, aliquots of 5 mg mitochondria were centrifuged at 14000×g for 10 min at 4°C and the supernatants discarded. The pellets were used for immunization or frozen in liquid N 2 and stored at −80°C for up to 1 month.
Isolation of human liver mitochondria
Preparation of mitochondrial proteins
Preparation of mitochondrial total lysates
Mitochondria were re-suspended in 100 μL isotonic buffer and 300 μL of RIPA (1% NP-40, 0.
phosphate, and protease inhibitors pH 7.6) added and the solution incubated on ice for 30 min. Mitochondrial proteins were obtained by recovery of the RIPA lysate supernatant after centrifugation at 14000×g for 30 min at 4°C. Up to 8 mg of mitochondrial proteins could be prepared from 1 g of liver tissue using this method.
Preparation of fractionated mitochondrial proteins
Mitochondrial proteins were fractionated into 8 fractions according to their molecular weight, as determined by SDS-PAGE. The molecular weight ranges of the 8 fractions obtained were; fraction 1 (≥100 kD), fraction 2 (75-100 kD), fraction 3 (62-75 kD), fraction 4 (50-62 kD), fraction 5 (43-50 kD), fraction 6 (37-43 kD), fraction 7 (25-37 kD), fraction 8 (≤25 kD). The fractionated mitochondrial proteins were recovered from SDS-PAGE gels in positions corresponding to their expected MW, and electro-eluted using Electro-Eluter (Bio-Rad Model 422).
Generation and characterization of mAbs against human liver mitochondrial proteins
Mice were immunized with 0.5-1.0 mg of mitochondrial proteins or with isolated mitochondria particles containing equivalent amounts of the proteins. Individual mice were immunized with 100-200 μg of the 8 fractionated mitochondrial proteins. Hybridoma cells were generated following standard cell fusion and cloning procedures. Monoclonal antibodies (mAbs) were characterized by determining their antibody isotype, and their specificities towards mitochondrial proteins identified using ELISA and Western blot techniques.
Identification of mAb specificity using cDNA expression library screening
To determine the specific antigen recognized by each monoclonal antibody produced in this study, a λ expression Uni-ZAPâ XR pre-made liver cDNA library (Stratagene, La Jolla, CA, USA) was screened with selected hybridoma supernatants. The screening and identification procedure were performed in accordance with the manufacturer's instructions. Briefly, the cDNA library was plated onto 150 mm plates at 5×10 4 pfu/plate and nitrocellulose membranes impregnated with 10 mmol L −1 IPTG were used to induce cDNA expression and subsequent transfer of the proteins. Washed membranes were blocked overnight in TBST containing 1% skimmed milk at 4°C, and then incubated with primary antibody (hybridoma supernatant in blocking buffer diluted at 1 : 5-1 : 100) for 2 h at 37°C. Bound antibodies were detected using horse radish peroxidase (HRP)-conjugated goat anti-mouse IgG with the ECL detection system (Amersham Pharmacia Biotech). The plaques corresponding to each positive spot on the film were cored, and the phage particles released into TBS buffer. To verify a positive clone, a second round of membrane screening was performed by plating the released phage pool onto 150 mm plates at a density of 1×10 3 -3×10 3 pfu/plate, following the same procedure as for the primary screening. At such low plating densities, individual positive clones could be readily isolated from the plates. The inserted cDNA sequences from the positive phages were transferred into a pBluescript phagemid (pBluescript SK + ) for sequencing after in vivo excision following the manufacturer's instructions. A BLAST was used to interrogate the sequencing data (GenBank). Because the inserted cDNA in pBluescript SK + can be induced to express recombinant protein in Escherichia coli, SDS-PAGE and western blots were used to validate antigen expression and antigen-antibody reactions. The E. coli SOLR strain containing pBluescript SK + were induced using 1 mmol L −1 IPTG for 3 h at 30°C when cultures reached an A 600 of 0.3. Bacterial proteins were loaded onto SDS-PAGE gels and western blotted. The SOLR strain containing an empty vector, pBluescript SK − , was used as a negative control.
Immunohistochemistry and immunofluorescence staining
To assess whether the mAbs produced in this study could recognize the mitochondria within liver cells, immunohistochemistry staining of liver tissues and immunofluorescent staining of liver carcinoma cells were performed. Frozen sections were fixed in dimethyl ketone for ten min at 4°C. After washing in TBST for 5 min, slides were incubated for 30 min in 3% hydrogen peroxide in methanol at room temperature to quench any endogenous peroxidase activity. After washing 3 times with TBST, the slides were blocked for 30 min with normal goat serum at room temperature. Primary antibodies were applied to the blocked sections and incubated overnight at 4°C. Positive signals were visualized using diaminobenzidine tetrahydrochloride (DAB) solution, after a 20 min incubation of the slides at 37°C with HRP-labeled goat anti-mouse IgG antibody (GBI, Beijing, China). Slides were counter-stained with hematoxylin for 5 min and washed in deionized H 2 O for 1 min.
Rhodamine 123 (green) was used to visualize mitochondria in live liver carcinoma cell preparations (Huh7) and mAb binding detected using TRITC-conjugated AffiniPure Goat Anti-Mouse IgG (H+L) (red) for double staining. Monolayer cells were cultured in RPMI 1640 containing 1 µg mL −1 Rhodamine 123 for 30 min at 37°C, and the cells fixed in TBS containing 4% paraformaldehyde and 0.2% Triton-100 for 20 min at 4°C. Fixed cells were washed 3 times with PBS and incubated with primary antibodies overnight at 4°C. Cells were incubated with the secondary antibody for 30 min at 37°C. After washing 3 times, the slides were analyzed using fluorescence microscopy (Olympus, Tokyo, Japan).
Depletion of antigenically dominant proteins from human liver mitochondria protein extracts
Purified mAb BAH103 (100 µg) was incubated with 100 μL Protein G agarose suspension (Pierce) overnight at 4°C in a total of 600 μL PBS buffer. After washing 3 times with PBS, 1 mg of the mitochondrial proteins were added to the mAbProteinG-agarose mix and incubated at 4°C for 3 h. Proteins that did not bind mAbs were loaded onto SDS-PAGE gels and western blotted. Proteins that did not bind mAbs were used to immunize mice to generate anti-sera.
Results and discussion
Isolation of human liver mitochondrial proteins
Mitochondria are one of the most important organelles for the maintenance of cell life. Given the contribution of mitochondria to the normal physiology and pathology of the cell, it is not surprising that this organelle contains around 1200 proteins. Although the exact number of mitochondrial proteins in mammals is not known, about 600-700 have been characterized [31] . In this study we used homogenization and standard differential centrifugation techniques to isolate mitochondria from human liver tissue, and isolated 48 mg of mitochondrial protein from 10 g of liver. The isolated mitochondria were lysed, and the total mitochondrial protein content analyzed using 1D and 2D-PAGE [30] , and succinate dehydrogenase activity testing (data not shown). This confirmed the purity and enrichment of the mitochondrial protein in the samples. Using PDQuest software (Ver 7.0, Bio-Rad) the MW and isoelectric point (pI) of each spot were analyzed. This revealed that the MW and pI for most of the proteins ranged between 20 and 80 kD and pH 3-8. These data are consistent with those obtained in previous studies of mitochondrial proteomes [3] . The MW of the most abundant proteins ranged between 30 and 80 kD (as determined by 1D and 2D-PAGE). Fractionated mitochondrial proteins were analyzed using SDS-PAGE ( Figure 1A ). The sera of the mice immunized with the fractionated mitochondrial proteins were analyzed by Western blot ( Figure  1B ).
Generation and characterization of mAb hybridoma cell lines
Antibodies, especially mAbs, are one of the most powerful tools in contemporary biological research. Analysis of cell or tissue protein profiles using antibody microarray technology, however, requires access to large quantities of well-characterized antibodies [4] . To establish a platform for large scale antibody production, we raised hybridoma cell lines from BALB/c mice immunized with mitochondrial protein mixtures isolated from human liver preparations. All of the 244 monoclonal hybridomas we established were tested for their isotypes. Isotype testing revealed that 89.8% were IgG1, 3.2% were IgG2a, and 4.9% were IgG2b (Table 1) . These mAbs were further characterized by western blotting using the hybridoma supernatants. The data for some of these experiments are shown in terns observed on western blots (Figure 2 ).
Antigen identification using a human liver cDNA expression library
Many methods have been developed to detect antigens produced by individual bacterial colonies or phage plaques; these recombinant proteins can be identified using a primary antibody against the protein of interest. Alternatively, isolation of full length or partial protein-encoding genes from large recombinant cDNA libraries can also be achieved using antibodies. Such coding sequences can be used for large scale recombinant protein expression to facilitate functional and structural analyses of protein antigens. In this study, 129 mAbs raised against human liver mitochondrial proteins were detected using a human liver cDNA expression library to determine the specificities of the mAbs. We identified 78 mAbs that were specific for 10 different protein types. Six of these proteins could be classified as antigenically dominant (Tables 2 and 3 ) and at least 2 hybridoma cell lines could be produced for each of the six proteins. Table 2 shows the 30 hybridoma cell lines that recognize carbamoyl phosphate synthetase 1 (CPS1). The hybridoma cell lines were obtained from mice immunized with fractionated or total mitochondrial protein preparations. These results show that CPS1 is the dominant protein antigen within mitochondria. CPS1 is believed to be one of the most abundant proteins in the liver, comprising approximately 4% of the total protein content of this organ [32, 33] . It is possible, therefore, that relatively high levels of this protein in the mitochondria could influence immune responses, as has been suggested previously where it was found that antigen priming was dose dependent [34] .
In protein mixtures, we found that some, but not all of the most abundant proteins were antigenic, whilst some, but not all of the antigenic proteins were abundant. We also found that the number of hybridoma cell lines derived from mice immunized with the fractioned mitochondria proteins was greater than the number of hybridoma cell lines derived from mice immunized with the mitochondria protein extracts. This could indicate that the six proteins identified are antigenically dominant proteins within mixtures (across a range of different molecular weights) (Tables 2 and 3 ). The six proteins were more antigenic in the fractioned mitochondria preparations compared to the unfractionated material. This could be because the representation of the mitochondrial proteins in the fractioned sample was less than that of the unfractionated samples; however, each individual protein present in the fractionated samples will be present in greater quantity. Thus, following fractionation, proteins that were not found to be strongly antigenic in the unfractionated material became immunodominant. Supporting this hypothesis, the hybridoma Acetyl-Coenzyme A acyltrans- ferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) (ACAA2) cell lines were only obtained from mice immunized with fractioned mitochondria proteins. These findings indicate that protein fractionation may be a good method for producing mAbs. In addition, western blot analysis of the bacteria proteins expressed from all the positive clones further demonstrates that recombinant proteins expressed by positive clones can be recognized by the corresponding hybridoma cell culture supernatants, at their expected MWs (Figure 3 ). The mAb identification success rate using this approach was around 50%; this rate might be related to factors such as the capacity of the cDNA library and the length of the inserted sequences. Because the average length of the inserts was 1.6 kb in the cDNA library used in this study, only partial sequences of the genes encoding proteins with large MWs were probably present in the phage library (Table 3) . Furthermore, negative results will be obtained when the epitopes recognized by the mAbs are not located within the peptide expressed by the phage library. Positive clones will not be obtained either, if the mAbs recognize epitopes within a protein that require posttranslational modifications. Therefore, it is not possible to identify all mAbs using cDNA expression libraries.
In the newly published database 'Liverbase', 6789 human liver proteins were identified by mass spectrometry that contained 2-117 unique peptides. All of the six proteins identified by the mAbs in this study are included (http:// liverbase.hupo.org.cn/liverbase/) in this database. The number of unique peptides for each protein could be an indicator of the abundance of a protein in the liver. Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) was listed as protein number 3339 in the database. Only three unique peptides are associated with it in the database (the lowest number of unique peptides of all the six antigenically dominant proteins). We generated forty four hybridoma cell lines for ALDH1A1 in the present studies (the highest number of hybridoma cell lines for the six antigenically dominant proteins). Acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase (ACAA2) (protein number 59) was shown to contain thirty eight unique peptides (the highest number of unique peptides of the six antigenically dominant proteins). We generated only three hybridoma cell lines for ACAA2 in our study (close to the lowest number of hybridoma cell lines for the six antigenically dominant proteins). We believe that identification of the six antigenically dominant proteins recognized by our mAbs was not only affected by their relative abundance in the liver (or number of unique peptides), but also by antigenic and/or other factors such as amino acid sequence homology between the murine and human orthologues. Previous reports indicated that these six proteins have important cellular functions, some of which could be related with pathology. CPS1, normally found in hepatocytes and small-intestine (SI) enterocytes, is the rate-limiting enzyme that catalyzes the first step of the hepatic urea cycle. Deficiency in this enzyme results in an autosomal recessive disorder associated with hyperammonemia, protein intolerance, and impaired mental and physical development. The incidence of CPS I deficiency in Japan is 1 : 800000 [35] . Recently, researchers found that expression of CPS1 in invasive small-intestine adenocarcinoma appears to be lost [36] . This could make this enzyme a diagnostically useful tool for identifying malignant tumors of the small-intestine.
Dihydrolipoamide acetyltransferase (DLAT) is one of six components of the mammalian pyruvate dehydrogenase complex (PDC) of the inner mitochondrial membrane. Patients with primary biliary cirrhosis (PBC; 109720), have autoantibodies against DLAT. Pyruvate dehydrogenase de-ficiency is a major cause of primary lactic acidosis and neurological dysfunction in infancy and early childhood. Some researchers reported patients with pyruvate dehydrogenase deficiency caused by defects in the E2 subunit. Episodic dystonia was the major neurological manifestation, with other more common features of pyruvate dehydrogenase deficiency, such as hypotonia and ataxia, being less prominent. The patients had neuroradiological evidence of discrete lesions restricted to the globus pallidus [37] .
The ALDH1A1 protein is quite abundant in mouse liver [38] , suggesting that a major function for this enzyme could be removal of toxic substances. There is evidence that ALDH1A1 functions downstream of alcohol dehydrogenase (ADH1) in the oxidative clearance of excess retinol through metabolism to retinoic acid (RA). ALDH1A1 plays a dominant role in the second stage of retinol clearance in adult mice. Vitamin A (retinol) is an essential nutrient for developmental regulation but is toxic in large amounts. A loss of ALDH1A1 results in accumulation of retinaldehyde produced by ADH1. Thus, ALDH1A1 may function to protect against alcohol or aldehyde toxicity in adults [39] . The enzyme is also highly expressed in non-small cell lung cancer and its downregulation is known to affect cell growth, cell motility and gene expression in lung cancer cells [40] . ALDH1A1 is also expressed at high levels in stem cells. Hematopoietic cells from Aldh1a1-deficient mice exhibit increased sensitivity to cyclophosphamide in a non-cellautonomous manner, consistent with a role in cyclophosphamide metabolism in the liver [41] . ALDH1A1 is also associated with resistance to cyclophosphamide (CP) and its derivatives [42] . Interestingly, polymorphisms in ALDH1A1 are correlated with an increased risk of liver toxicity [43] .
ACAA2 is involved in β-oxidation of fatty acids. Fatty acids are important metabolic fuels, particularly at times of stress or fasting. They are predominantly metabolized in mitochondria, by a process requiring activation, transport into the mitochondria, and subsequent conversion to acetyl-CoA by β-oxidation. This sequence of events may be impaired by genetic or environmental factors. A number of patients have been identified with defects in mitochondrial fatty acid oxidation. The clinical features in these patients include hypoketotic hypoglycemic coma, sudden infant death syndrome, Reye-like episodes, muscle weakness, and cardiomyopathy [44] . Researchers found ACAA2 could attenuate the apoptotic effects of BNIP3 in two human cell lines [45] .
ECH1 is the second enzyme in the β-oxidation pathway. Down-regulation of ECH1 activity is correlated with resistance of B-CLL (B-cell chronic lymphoid leukemia) cells to DNA damage-induced apoptosis. In this study, 13 genes were found to be specific for all resistant B-CLL cell samples, all of which were down-regulated, including ECH1 [46] .
Hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), plays an important role in regulating cortisol availability in target tissues. The enzyme is a primary regulator catalyzing the reduction of inactive cortisone to active cortisol. Glucocorticoid excess promotes visceral obesity and cardiovascular disease. Ligand availability to the glucocorticoid receptor is controlled by HSD11B, which also plays a crucial role in the pathogenesis of obesity and controls glucocorticoid action in inflammation. Expression of HSD11B1 was found to be significantly elevated in inflamed tissue compared to non-inflamed colon tissue [47] . Several studies have indicated that HSD11B1 plays a crucial role in the onset of type 2 diabetes. Glucocorticoid action is linked to the development of obesity and insulin resistance. Recently, inhibition of HSD11B1 has been proposed as a strategy to suppress glucocorticoid action in a tissue-specific manner [48] . There is also preliminary evidence supporting an association of HSD11B1 with osteoporosis in postmenopausal women [49] . In this case, increased HSD11B1 expression in fibroblasts could be a mechanism for increasing local cortisol levels in membranes, which could potentiate the osteolytic process through inhibition of osteoblastic function [50] .
Studies on the induction of hepatic HSD11B1 in patients with alcoholic liver disease have shown mRNA expression of the enzyme was increased fivefold in the alcoholic liver disease (ALD) group compared with normal controls. These results show that significant induction of HSD11B1 gene expression and activity occurs in patients with ALD during short-and long-term abstinence from alcohol. The mechanism underlying this is unknown, but might be explained on the basis of alcohol-induced changes in intracellular redox potential, or as a protective mechanism to limit liver inflammation and injury. Selective HSD11B1 inhibitors may offer a novel therapeutic approach to treat alcoholic pseudo-Cushing's syndrome [51] .
Subcellular localization of antibody-antigens complexes
To detect the antigens recognized by mAb localization in liver tissue, liver tissue slides were stained with selected mAbs and analyzed using fluorescence immunohistochemistry. The results showed that all mAbs had similar dotted staining patterns which localized in the cytoplasm ( Figure  4A ). To demonstrate that the characteristic dotted staining was mitochondrial in origin, a double staining assay was performed. In these experiments, Rhodamine 123, (a green mitochondrial stain) and red TRITC conjugated goat anti-mouse IgG co-localized in the cytoplasm of the liver cells ( Figure 4B, yellow) . Hence, the mAbs generated in this study will provide useful tools as mitochondrial markers, and for labeling or isolating mitochondria.
Depletion of antigenically dominant proteins from human liver mitochondrial proteins
The successful purification and identification of low abun- dance proteins is currently a significant challenge in proteomic research. Depletion of highly abundant proteins from proteomic samples is a commonly used strategy to enrich low abundance proteins. In the present study, native proteins of unknown identity were used to immunize mice and generate mAbs that could be used to recognize native proteins in human liver samples (as described in Materials and methods). As expected, antibodies against some proteins that were relatively abundant and immunodominant in the mixtures were generated. Antibody specificity was determined using an established antibody specificity identification platform. The mAbs were found to be highly effective at depleting their cognate proteins from the liver samples. In these experiments, we used a new mAb designated BAH103, to deplete ECH1 from human liver mitochondria protein samples using immunoprecipitation (IP). No positive bands were observed in the BAH103 depleted liver lysates, as determined by western blot analysis, indicating that ECH1 had been successfully depleted from the samples ( Figure 5B ). ECH1 depleted protein preparations were used to immunize mice. Western blots using the antiserum obtained revealed an absence of bands at positions corresponding to the molecular weight of ECH1 ( Figure 5A and B). Other mAbs, such as BEH045, which was raised against CPS1 (one of the antigenically dominant proteins in liver mitochondria), were used to isolate enzymatic complexes from human liver mitochondria. These mAbs were also be used to deplete their corresponding antigen from human liver mitochondrial protein using IP [30] . These results provide strong impetus to generate mAbs against the less abundant or less immunodominant proteins present in liver samples. This can be achieved using liver samples where the immunodominant proteins are first depleted.
Conclusion
In conclusion, monoclonal antibodies against highly abundant or dominant liver mitochondrial proteins can be raised by immunizing mice with fractionated human liver mitochondrial proteins. Such mAbs have great potential to be- 
